Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-30

Clinical Trial Update: Safety Study of Ibuprofen to Treat Acute Traumatic Spinal Cord Injury [Phase 1]

View source ↗

Summary

A Phase 1 safety study of ibuprofen for acute traumatic spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Jan M. Schwab, MD, PhD | Conditions: Spinal Cord Injury | Phase 1 | Status: COMPLETED